Holen Sie sich die Stockscreener-App
1.29
0.77%
-0.01
Vorhandelsmarkt:
1.24
-0.05
-3.88%
Schlusskurs vom Vortag:
$1.30
Offen:
$1.33
24-Stunden-Volumen:
50,411
Relative Volume:
0.62
Marktkapitalisierung:
$3.79M
Einnahmen:
$202.00K
Nettoeinkommen (Verlust:
$-28.96M
KGV:
-2.15
EPS:
-0.6
Netto-Cashflow:
$-21.85M
1W Leistung:
+14.16%
1M Leistung:
-6.52%
6M Leistung:
-85.42%
1J Leistung:
+452.70%
1-Tages-Spanne:
$1.26
$1.33
1-Wochen-Bereich:
$1.1099
$1.33
52-Wochen-Spanne:
$0.0633
$20.35
AIM ImmunoTech Inc Stock (AIM) Company Profile
Firmenname
AIM ImmunoTech Inc
Sektor
Branche
Telefon
352 448 7797
Adresse
2117 SW Highway 484, Ocala, FL
Vergleichen Sie AIM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AIM
AIM ImmunoTech Inc
|
1.29 | 3.82M | 202.00K | -28.96M | -21.85M | -0.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
AIM ImmunoTech Inc Aktie (AIM) Neueste Nachrichten
AIM ImmunoTech: One Shr for Every 1,000 Shrs or for Every Outstanding Option or Warrant Having a Right to Stk Dividends >AIM - 富途牛牛
AIM ImmunoTech Announces Stock Dividend - The Manila Times
AIM ImmunoTech to give extra shares to investors via stock dividend - Stock Titan
AIM ImmunoTech receives NYSE American notice of delisting and appeal - MSN
Published on: 2025-12-21 18:10:19 - Улправда
Why AIM ImmunoTech Inc. (HXB) stock is a must watch tickerPortfolio Value Report & Stepwise Entry/Exit Trade Alerts - Улправда
How AIM ImmunoTech Inc. (HXB) stock performs during market turbulenceJuly 2025 Recap & Trade Opportunity Analysis Reports - DonanımHaber
Will AIM ImmunoTech Inc. stock benefit from sector leadershipRate Cut & Real-Time Price Movement Reports - DonanımHaber
Published on: 2025-12-19 13:37:56 - Улправда
AIM ImmunoTech Completes 2025 Annual Stockholder Meeting - TipRanks
[8-K] AIM ImmunoTech Inc. Reports Material Event | AIM SEC FilingForm 8-K - Stock Titan
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B - Benzinga
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B - Sahm
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B (2025-12-16) - Seeking Alpha
AIM ImmunoTech Announces Release of the Next CEO Corner Segment - Yahoo Finance
Ascendiant Capital Maintains AIM ImmunoTech (AIM) Buy Recommendation - Nasdaq
Ascendiant Capital lowers AIM ImmunoTech stock price target to $22 on valuation - Investing.com Nigeria
Ascendiant Capital lowers AIM ImmunoTech stock price target to $22 on valuation By Investing.com - Investing.com South Africa
AIM: Analyst Maintains 'Buy' Rating, Lowers Price Target | AIM S - GuruFocus
Would You Still Hold AIM ImmunoTech Stock If It Fell Another 30%? - Trefis
How AIM ImmunoTech Inc. stock compares with tech leadersEarnings Recap Summary & Growth-Oriented Investment Plans - Newser
Will AIM ImmunoTech Inc. stock benefit from Fed rate cutsMarket Trend Report & Free Technical Confirmation Trade Alerts - Newser
How AIM ImmunoTech Inc. stock reacts to new regulations2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Will AIM ImmunoTech Inc. stock deliver compounding returnsJuly 2025 Earnings & Daily Risk Controlled Trade Plans - Newser
Can AIM ImmunoTech Inc. stock expand revenue streamsDollar Strength & Fast Moving Stock Trade Plans - Newser
AIM ImmunoTech (NYSEAMERICAN:AIM) Cut to Hold at Zacks Research - Defense World
Is AIM ImmunoTech Inc. (HXB) stock resilient in recession scenariosJuly 2025 Setups & Free Accurate Trade Setup Notifications - Newser
Why AIM ImmunoTech Inc. stock fits value portfoliosQuarterly Market Summary & Verified Momentum Watchlists - Newser
Can AIM ImmunoTech Inc. (HXB) stock sustain margin levels2025 Institutional Moves & Fast Exit and Entry Trade Guides - Newser
Is AIM ImmunoTech Inc. stock supported by strong fundamentals - Newser
AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series - The Manila Times
An analyst sees good growth prospects for AIM ImmunoTech Inc (AIM) - setenews.com
Published on: 2025-11-27 17:32:11 - moha.gov.vn
AIM ImmunoTech Inc. (AIM) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
AIM ImmunoTech Inc. (AIMI) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
AIMAIM ImmunoTech Inc Forecast, Target Price - Finviz
What analyst consensus implies for AIM ImmunoTech Inc. (HXB) stock2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Why global investors buy AIM ImmunoTech Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com
Will AIM ImmunoTech Inc. (HXB) stock deliver stable dividends2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
How AIM ImmunoTech Inc. (HXB) stock behaves under inflation pressureMarket Movers & Real-Time Chart Breakout Alerts - newser.com
Is AIM ImmunoTech Inc. (HXB) stock vulnerable to rate hikesQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
Can AIM ImmunoTech Inc. stock deliver strong annual returnsJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
Is AIM ImmunoTech Inc. stock a buy on weaknessJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Finanzdaten der AIM ImmunoTech Inc-Aktie (AIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
28.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):